Product logins

Find logins to all Clarivate products below.


Vascular Closure Devices – Market Insights – Global

The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth will be limited by the continued shift from femoral to radial access.

This Medtech 360 Report provides comprehensive data and analysis on the state of the global market for VCDs from 2019 through 2034.

The increasing adoption of the percutaneous approach for both cardiac and PV interventions will drive VCD market growth.

Which procedure types will experience the fastest growth?

Will procedure volumes requiring large access grow at a different pace than those requiring small access?

How will different trends affect the adoption of the various VCD product types?

The pace of adoption of radial access—particularly in cardiac smallaccess procedures—varies between countries.

How have guidelines adapted to the growing volume of clinical evidence supporting the benefits of radial access?

In which countries will this trend have the greatest impact?

How will the continued transition from femoral to radial access affect the VCD market?

Product innovation and M&A activity will reshape the competitive landscape in the coming years.

What areas of improvement are current vascular innovations targeting?

Which M&A have recently occurred, and will they lead to shifts in the global market?

On which anatomies and accesssite sizes is ongoing clinical research focused?

Table of contents


Related Medtech Insights Reports

Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Neurovascular Devices – Market Insights – Latin America
The Latin American neurovascular device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing…